Targeting CD2 for immunotherapy: Results of a phase 1 trial with a LFA-3/IgG Fe fusion protein.

被引：0
|
作者：
Magilavy, D
Norman, P
Majeau, G
Knox, S
Winkler, G
MacLellan, S
Sartori, L
Cooney, M
Meier, W
Hochman, P
Rogge, M
机构：
[1] Biogen Inc, Cambridge, MA 02142 USA
[2] UMDS, Guys Hosp, London, England
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1998年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：682 / 682
页数：1
相关论文
共 50 条
  • [31] PHYSICAL LINKAGE OF GENES ENCODING THE LYMPHOCYTE ADHESION MOLECULES CD2 AND ITS LIGAND LFA-3
    KINGSMORE, SF
    WATSON, ML
    MOSELEY, WS
    SELDIN, MF
    IMMUNOGENETICS, 1989, 30 (02) : 123 - 125
  • [32] THE LYMPHOCYTE FUNCTION-ASSOCIATED LFA-1, CD2, AND LFA-3 MOLECULES - CELL-ADHESION RECEPTORS OF THE IMMUNE-SYSTEM
    SPRINGER, TA
    DUSTIN, ML
    KISHIMOTO, TK
    MARLIN, SD
    ANNUAL REVIEW OF IMMUNOLOGY, 1987, 5 : 223 - 252
  • [33] Accessory function of endothelial cells in anti-CD3 induced and allogenic T cell stimulation consists of LFA-1/ICAM and CD2/LFA-3 interactions
    Westphal, HR
    Willems, RW
    Tax, WJM
    Koene, RAP
    Ruiter, DJ
    deWaal, RMW
    IMMUNOLOGY, 1996, 89 : SH33 - SH33
  • [34] ONLY DULL CD3+ THYMOCYTES BIND TO THYMIC EPITHELIAL-CELLS - THE BINDING IS ELICITED BY BOTH CD2/LFA-3 AND LFA-1/ICAM-1 INTERACTIONS
    NONOYAMA, S
    NAKAYAMA, M
    SHIOHARA, T
    YATA, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (09) : 1631 - 1635
  • [35] ACTIVATION OF CORD T-LYMPHOCYTES .3. ROLE OF LFA-1/ICAM-1 AND CD2/LFA-3 ADHESION MOLECULES IN CD3-INDUCED PROLIFERATIVE RESPONSE
    GERLI, R
    AGEA, E
    MUSCAT, C
    TOGNELLINI, R
    FIORUCCI, G
    SPINOZZI, F
    CERNETTI, C
    BERTOTTO, A
    CELLULAR IMMUNOLOGY, 1993, 148 (01) : 32 - 47
  • [36] MOUSE LFA-3 STUDIED WITH CHIMERIC SOLUBLE CD2 SHOWS PREFERENTIAL EXPRESSION ON LYMPHOID-CELLS
    RUTSCHMANN, R
    KARJALAINEN, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (06) : 1379 - 1384
  • [37] A MONOCLONAL-ANTIBODY TO LFA-3, THE CD2 LIGAND, SPECIFICALLY IMMOBILIZES MAJOR HISTOCOMPATIBILITY COMPLEX PROTEINS
    BIERER, BE
    GOLAN, DE
    BROWN, CS
    HERRMANN, SH
    BURAKOFF, SJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (04) : 661 - 665
  • [38] LFA-3/CD2 Pathway, Potential Target For Immunosuppressive Therapy In Aplastic Anemia: A Phase I/II Trial Of Alefacept In Patients With Relapsed/Refractory Aplastic Anemia
    Tiu, Ramon V.
    Visconte, Valeria
    Elson, Paul
    Clemente, Michael J.
    Tabarroki, Ali
    Hasrouni, Edy
    Porter, Amy
    Mooney, Lindsey
    Afable, Manuel G., II
    Englehaupt, Ricki
    Juersivich, Joy
    Cooper, Kathleen
    Sekeres, Mikkael A.
    Saunthararajah, Yogen
    Maciejewski, Jaroslaw P.
    BLOOD, 2013, 122 (21)
  • [39] THE LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN (LFA)-1 AND CD2/LFA-3 PATHWAYS OF ANTIGEN-INDEPENDENT HUMAN T-CELL ADHESION
    SHAW, S
    LUCE, GEG
    JOURNAL OF IMMUNOLOGY, 1987, 139 (04): : 1037 - 1045
  • [40] THE CD2 LIGAND LFA-3 ACTIVATES T-CELLS BUT DEPENDS ON THE EXPRESSION AND FUNCTION OF THE ANTIGEN RECEPTOR
    BOCKENSTEDT, LK
    GOLDSMITH, MA
    DUSTIN, M
    OLIVE, D
    SPRINGER, TA
    WEISS, A
    JOURNAL OF IMMUNOLOGY, 1988, 141 (06): : 1904 - 1911
12345